trial

Adjunctive iTBS for First-Episode Schizophrenia

NCTId NCT07116850
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 100 (actual)
Sponsored by The First Hospital of Hebei Medical University
Primary completion 2024-12-31
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
100 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2024-01-01
Primary completion
2024-12-31
Eligibility
ALL · 18 Years · 45 Years

Interventions & indications

Drugs
Intermittent Theta-Burst Stimulation (iTBS)RisperidoneCognitive Behavioral Therapy (CBT)

Sponsors

The First Hospital of Hebei Medical UniversityLead Sponsor

Sites

1 total
Shijiazhuang, China

Facts & assertions

4 sourced
Enrollment
100
Phase
NA
Primary Completion Date
2024-12-31
Status
COMPLETED
relationships
The graph out of here
drug
Intermittent Theta-Burst Stimulation (iTBS)
drug
Risperidone
drug
Cognitive Behavioral Therapy (CBT)
drug
lead_sponsor
The First Hospital of Hebei Medical University
company
indication
Schizophrenia
indication
Schizophrenia Disorder
indication